...N.Y. Business: Renal, Musculoskeletal, Pulmonary Date completed: 5/7/12 Type: Venture financing Raised: $4 million Investors: MSMB Capital...

...a process to explore and evaluate strategic alternatives, including a sale. In June, hedge fund MSMB Capital Management LLC...

...Neoprobe filed a formal response to a June 2 Citizen's Petition submitted by hedge fund MSMB Capital...

...to AMAG shareholders, ISS supported neither the merger nor an an unsolicited offer made by MSMB Capital Management LLC...

...was first announced, it valued Allos at $258 million (see BioCentury, July 25). Separately, investor MSMB Capital Management LLC...

...than $500 million (see BioCentury, July 25). In August, AMAG rejected an offer from shareholder MSMB Capital...

...$1.64 (see BioCentury Extra, July 20) . In August, AMAG rejected an offer from shareholder MSMB Capital...

...potential deal. Last week, it rejected an $18 per share cash bid ($380.9 million) from MSMB Capital...

...$0.85 to $14.97 last week after its board unanimously rejected an unsolicited offer from shareholder MSMB Capital...

...Neoprobe filed a formal response to a June 2 Citizen's Petition submitted by hedge fund MSMB Capital...